{"title":"Challenges faced by celiac disease patients during the COVID-19 pandemic.","authors":"Faeze Shojaei Cherati, Fahimeh Kamali, Elnaz Kiani","doi":"10.22037/ghfbb.v16i2.2739","DOIUrl":null,"url":null,"abstract":"1 Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) that first appeared in humans caused global coronavirus disease pandemic (COVID-19). The highly contagious viral infection known as COVID-19 first surfaced in Wuhan, China, which has spread worldwide. Numerous studies showed that human-tohuman transmission quickly spreads, but the origin, and method of transmission before the transfer to humans are unknown (1). Multiple countries have implemented significant public health measures, such as physical separation, the suspension of public transportation, curfews, and even lockdowns, to reduce the transmissions, and flatten the curve of infections. As a result of the enforced restrictions and unusual circumstances, the majority of people became socially isolated, resulting in physical and mental health problems for the general public (2). These precautions restricted people's access to marketplaces and businesses which provided food, as well as to typical medical appointments (3, 4). Patients with chronic conditions such as celiac disease (CeD) were limited in order to prevent congestion in healthcare institutions (5). The continuity of care for the patients with chronic disorders, particularly those with celiac disease (CeD),","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 2","pages":"110-111"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/93/7e/GHFBB-16-110.PMC10404829.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gastroenterology and Hepatology From Bed to Bench","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22037/ghfbb.v16i2.2739","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
1 Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) that first appeared in humans caused global coronavirus disease pandemic (COVID-19). The highly contagious viral infection known as COVID-19 first surfaced in Wuhan, China, which has spread worldwide. Numerous studies showed that human-tohuman transmission quickly spreads, but the origin, and method of transmission before the transfer to humans are unknown (1). Multiple countries have implemented significant public health measures, such as physical separation, the suspension of public transportation, curfews, and even lockdowns, to reduce the transmissions, and flatten the curve of infections. As a result of the enforced restrictions and unusual circumstances, the majority of people became socially isolated, resulting in physical and mental health problems for the general public (2). These precautions restricted people's access to marketplaces and businesses which provided food, as well as to typical medical appointments (3, 4). Patients with chronic conditions such as celiac disease (CeD) were limited in order to prevent congestion in healthcare institutions (5). The continuity of care for the patients with chronic disorders, particularly those with celiac disease (CeD),